Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1460 of 5804
-
New Light-Based sensor could replace invasive heart monitoring
Diagnosis CompletedLeft ventricular filling pressure (LVFP) monitoring has been associated with improved quality of life, survival and reduced hospitalization rates. However, current LVFP monitoring methods are invasive, costly, and require long-term antithrombotic therapy. The purpose of this stu…
Sponsor: Seerlinq s. r. o. • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Can an iPad app lift mood and sharpen mind after stroke?
Symptom relief Recruiting nowIndividuals with stroke commonly experience both depression and cognitive difficulties. The goal of this study is to evaluate the efficacy of a treatment that combines a digital therapeutic (an iPad-based cognitive training program) with learning cognitive strategies. The hypothe…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New ACL implant under Real-World watch: does it hold up?
Disease control OngoingThe purpose of the Bridge Registry is to assess real-world performance of the FDA approved BEAR Implant.
Sponsor: Miach Orthopaedics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Vitamin c and iron combo takes on brain cancer in early trial
Disease control OngoingThis clinical trial evaluates adding ferumoxytol and pharamcologic ascorbate (vitamin C) to standard of care treatment of glioblastoma multiforme (a type of brain tumor) in adults. All subjects will receive ferumoxytol and pharmacologic ascorbate in addition to the standard treat…
Phase: PHASE1 • Sponsor: Bryan Allen • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Lymph-Draining catheter could ease fluid overload in heart failure
Disease control Recruiting nowThe goal of this feasibility study is to evaluated the safety and performance of the WhiteSwell eLym System in the treatment of fluid overload or congestion in adult patients with Acute Decompensated Heart Failure (ADHF). The main question\[s\] it aims to answer are: * Acute dev…
Phase: NA • Sponsor: WhiteSwell, Limited • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New sublingual film could make opioid withdrawal less miserable
Symptom relief OngoingA major challenge to seeking treatment for opioid use disorder (OUD) is the withdrawal symptoms associated with cessation of opioid use. The signs and symptoms of opioid withdrawal include irritability, anxiety, muscular and abdominal pains, chills, nausea, diarrhea, yawning, run…
Phase: PHASE1, PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Inner ear implant aims to restore balance in dizzy patients
Disease control Recruiting nowAlthough cochlear implants can restore hearing to individuals who have lost cochlear hair cell function, there is no widely available, adequately effective treatment for individuals suffering chronic imbalance, postural instability and unsteady vision due to bilateral vestibular …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could six months of bupropion double quit rates for african american smokers?
Disease control Recruiting nowThis study will evaluate the efficacy of extended bupropion(6 months) versus standard bupropion treatment (7 weeks) among African American daily smokers.
Phase: PHASE3 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Zapping the brain to ease MS mental fog and mood
Symptom relief CompletedMultiple Sclerosis (MS) is an autoimmune disease associated with physical disability, psychological impairment, and cognitive dysfunction. As a result, the disease burden is high, and treatment options are limited. In this randomized, double-blind study, the investigators planned…
Phase: NA • Sponsor: The National Brain Mapping Laboratory (NBML) • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Dogs may help kids with autism control emotions, new study says
Symptom relief Recruiting nowThe primary objective is to evaluate the potential additive effect of animal-assisted intervention (AAI) on a manualized behavioral treatment targeting emotion dysregulation (ED) in children with autism spectrum disorder (ASD). Aim 1: Evaluate whether Regulating Together-Canine …
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Could a common cholesterol drug ease ulcerative colitis?
Disease control CompletedFibrates, which are specific pharmacological agonists of PPARα, have been widely used in the treatment of hypercholesterolemia and hypertriglyceridemia. Apart from their metabolic action, anti-inflammatory properties of fibrates have been described, including inhibition of NF-kap…
Phase: PHASE2, PHASE3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug DAOIB hopes to clear long COVID brain fog
Symptom relief Recruiting nowThis is a 24-week open trial. We will enroll long-COVID patients with cognitive impairments. All patients will receive DAOIB for 24 weeks. We will assess the patients every 8 weeks during the treatment period (weeks 0, 8, 16, and 24). We hypothesize that DAOIB treatment will be b…
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New hope for high cholesterol: Statin-Free drug shows promise in Year-Long study
Disease control CompletedA Multicenter, Open-label Study to assess the safety and efficacy of ETC-1002 at 180 mg administered for 52 weeks in patients with hyper-LDL cholesterolemia
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New oral drug shows promise in early arthritis trial
Disease control CompletedThis Phase IIa study is designed to evaluate the dose-response relationship, efficacy, safety, and tolerability of LW402 tablets administered for 12 weeks in adult patients with active rheumatoid arthritis receiving background methotrexate (MTX) therapy.
Phase: PHASE2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a pill end motion sickness for good?
Symptom relief OngoingAn open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Magnetic brain zaps could replace antidepressants for some patients
Symptom relief OngoingThis is a randomized, controlled trial in which 72 patients with depressive disorder were treated in two study arms using the non-invasive brain stimulation method of intermittent thetaburst intermittent theta burst stimulation (iTBS). This is a wait-list control study, and the …
Phase: NA • Sponsor: University of Regensburg • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Urine test could guide heart failure treatment and save lives
Disease control Recruiting nowAcutely decompensated heart failure (ADHF) is highly prevalent and has a high (financial) burden on the health care system. Treatment often consists of the administration of IV decongestive agents. Adequate dosing is difficult due to varying diuretic resistance and inadequate par…
Phase: NA • Sponsor: Zuyderland Medisch Centrum • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Lupus drug anifrolumab put to the test in Real-World study
Disease control OngoingAnifrolumab Study of Treatment Effectiveness in the Real World (ASTER) study will collect real world data to obtain a good understanding of the (sustained) clinical effect and patient quality of life outcomes among diagnosed SLE patients who initiate anifrolumab treatment. ASTER …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Magnetic chair may ease bladder leaks without drugs
Symptom relief CompletedUrinary incontinence is becoming an increasingly common health, social and economic problem. The prevalence of urinary incontinence is estimated at 55% of the entire female population. Urgency urinary incontinence (UUI) is the least common subtype of urinary incontinence but has …
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Symptom relief
Last updated Jun 26, 2026 16:31 UTC
-
COPD patients get a boost: peer coaching and video stories aim to boost rehab completion
Symptom relief Recruiting nowChronic Obstructive Pulmonary Disease (COPD) affects approximately 16 million Americans and is characterized by recurrent exacerbations that lead to 1.5 million Emergency Department visits and 700,000 hospitalizations annually. Pulmonary rehabilitation (PR) is a structured progra…
Phase: NA • Sponsor: Baystate Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC